Journal of Clinical & Experimental Radiology.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Current Status of Gadolinium Retention in the Brain

Gadolinium (Gd3+) based contrast agents previously demonstrated safe administration and were associated with minimal events of adverse reactions until NSF and gadolinium deposits were found in the brain. Gadolinium is a paramagnetic earth lanthanoid element with a ferromagnetic property that is suitable for intravenous administration. Recently, a series of studies raised their concern over the higher risk of developing NSF when administering nonionic linear agents such as gadodiamide and gadoversetamide

Special Features

Full Text

View

Track Your Manuscript

Recommended Conferences

Share This Page

Media Partners

Associations